Aims and scope

Expert Review of Endocrinology & Metabolism [ISSN 1744-6651]; [e-ISSN 1744-8417] is a MEDLINE-indexed, peer-reviewed journal providing extensive coverage of state-of-the-art research and clinical advancements in endocrine control and metabolism.

The journal is an essential contribution to decision-making for disorders of endocrinology and metabolism for all professionals within this specialty, encompassing the most stimulating and up-to-date topics in clinical diseases such as: diabetes, obesity, osteoporosis, thyroid disease, adrenal insufficiency and pituitary tumors, as well as disorders associated with growth, reproduction, weight management and hormone-regulated gene expression.

The journal focuses on the following key areas:

  • Screening, prevention and diagnostics
  • Existing and novel therapeutics
  • Related molecular genetics
  • Pathophysiology
  • Epidemiology

The journal welcomes clinically focused original research, reviews, editorials and drug profile articles.

Please note that the journal does not accept case reports and does not accept papers focused on pre-clinical work and/or animal studies.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Authors can choose to publish gold open access in this journal and may choose to publish using our Accelerated Publication services.

Read the Instructions for Authors for information on how to submit your article. For any pre-submission enquiries, please contact the Commissioning Editor.